Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. LEVO AG
WARNING LETTER
•LEVO AG•April 9, 2025

LEVO AG – FDA Warning Letter, Apr 9, 2025

Record Details

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to LEVO AG, a Swiss manufacturer of Class II Standup Wheelchairs, following an inspection conducted from April 7-9, 2025. The inspection revealed that LEVO AG"s medical devices are considered adulterated because their manufacturing processes and controls do not conform to the FDA"s Quality System regulation (21 CFR Part 820). The primary issue identified was a systemic failure to establish and maintain an appropriate quality system, with missing documentation across nearly all essential areas. These included management responsibility, quality audits, personnel training, design controls, document controls, purchasing controls, production and process controls, acceptance activities, nonconforming product procedures, corrective and preventive actions, labeling, packaging, and comprehensive record-keeping, including complaint files. Additionally, the firm failed to adequately establish and maintain medical device report procedures (21 CFR § 803.17) and did not provide required unique device identifier information for its products (21 CFR § 830.300).

While LEVO AG provided corrective action plans, including a temporary suspension of device exports to the U.S., the FDA determined the adequacy of these responses could not be confirmed without further evidence. To achieve compliance, the FDA requires LEVO AG to submit comprehensive documentation addressing all requirements of 21 CFR Part 820 and provide training records demonstrating adherence to these Quality System requirements.

Company
LEVO AG
Inspection date
April 9, 2025
Product type
Devices
Office
Office of Health Technology 5 (Neurological and Physical Medicine Devices)
Person
  • David McMullen (Director)
View Company Profile

ID · 1bb3abb2-2395-4426-a91a-72cd16e71f53

Violation Codes10
21 CFR 803.1721 CFR 82021 CFR 820.25021 CFR 820.2221 CFR 80321 CFR 820.5021 CFR 820.18121 CFR 820.198FD&C Act 201(h)21 U.S.C. 321(h)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore LEVO AG
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.